Short-term Osteoclastic Activity Induced by Locally High Concentrations of Recombinant Human Bone Morphogenetic Protein–2 in a Cancellous Bone Environment

Study Design. An experimental study investigating osteoclastic activity induced by rhBMP-2 in sheep. Objective. To examine the effects of increasing local rhBMP-2 concentration on osteoclastic response and peri-implant bone resorption. Summary of Background Data. Level I clinical studies have established the safe and effective volume and concentration of rhBMP-2 delivered on an absorbable collagen sponge. However, peri-implant bone resorption appearing as decreased mineral density has been observed radiographically in rare instances after implantation of rhBMP-2 on an absorbable collagen sponge (rhBMP-2/ACS). Methods. Bilateral corticocancellous defects were created in the distal femora of 30 adult sheep. Combinations of rhBMP-2/ACS implant volume (V) (1V = normal fill or 2V = overfilled) and rhBMP-2 solution concentration (×) (1× = normal concentration or 3.5× = hyperconcentrated) resulted in local rhBMP-2 concentrations of 0×, 1×, 2×, 3.5×, and 7× the estimated effective concentration for this model. Faxitron radiography, quantitative CT, histology, and quantitative histomorphometry were conducted in a blinded fashion to analyze the effect of the treatments. Results. At 1 week, the normal fill-normal concentration implants (1×) produced the least transient osteoclastic activity resulting in limited peri-implant resorption. Overfilled-hyperconcentrated implants (2×, 3.5×) demonstrated moderate resorption zones. Overfilled-hyperconcentrated implants (7×) demonstrated extensive osteoclastic activity and marked resorption. Results at 4 and 8 weeks revealed dense osteoid and bone in the voids with progressive bony healing. Control defects showed no osteoclastic activity with little to no bony healing. Conclusion. Increasing the local rhBMP-2 concentration by overfilling the defect with rhBMP-2/ACS or hyperconcen-trating the rhBMP-2 solution on the absorbable collagen sponge led to a concentration-dependent osteoclastic resorption of peri-implant bone. The osteoclastic effect was transient, and progressive healing took place over the 8-week survival period.

[1]  T. Smoljanović,et al.  Re: Kleeman TJ, Ahn UM, Talbot-Kleeman A. Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes. Spine 2001;26:2751-6. , 2010, Spine.

[2]  Tomislav Smoljanovic,et al.  Bone morphogenetic protein. , 2009, Journal of neurosurgery. Spine.

[3]  M. Pećina,et al.  Re: Burkus J K, Sandhu H S, Gornet M F. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft. Spine 2006;31:775-81. , 2008, Spine.

[4]  J. McClellan,et al.  Vertebral Bone Resorption After Transforaminal Lumbar Interbody Fusion With Bone Morphogenetic Protein (rhBMP-2) , 2006, Journal of spinal disorders & techniques.

[5]  H. Miraliakbar,et al.  Cantilever TLIF With Structural Allograft and RhBMP2 for Correction and Maintenance of Segmental Sagittal Lordosis: Long-Term Clinical, Radiographic, and Functional Outcome , 2006, Spine.

[6]  B. Rechenberg,et al.  An animal model in sheep for biocompatibility testing of biomaterials in cancellous bones , 2006, BMC musculoskeletal disorders.

[7]  H. Miyaji,et al.  Dentin resorption and cementum-like tissue formation by bone morphogenetic protein application. , 2006, Journal of periodontal research.

[8]  M. Spector,et al.  Comparing ectopic bone growth induced by rhBMP‐2 on an absorbable collagen sponge in rat and rabbit models , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  R. Delamarter,et al.  Graft Resorption With the Use of Bone Morphogenetic Protein: Lessons From Anterior Lumbar Interbody Fusion Using Femoral Ring Allografts and Recombinant Human Bone Morphogenetic Protein-2 , 2006, Spine.

[10]  R. Sasso,et al.  Resorptive Response of rhBMP2 Simulating Infection in an Anterior Lumbar Interbody Fusion With a Femoral Ring , 2006, Journal of spinal disorders & techniques.

[11]  J. Burkus,et al.  Influence of rhBMP-2 on the Healing Patterns Associated With Allograft Interbody Constructs in Comparison With Autograft , 2006, Spine.

[12]  K. Bulsara,et al.  Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. , 2005, Journal of neurosurgery. Spine.

[13]  J. Fischgrund,et al.  Bone morphogenetic proteins for spinal fusion. , 2005, The spine journal : official journal of the North American Spine Society.

[14]  B. Walters,et al.  Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes. , 2005, Journal of neurosurgery. Spine.

[15]  J. Burkus,et al.  Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. , 2005, The Journal of bone and joint surgery. American volume.

[16]  C. Shaffrey,et al.  Iliac Crest Bone Graft Donor Site Pain After Anterior Lumbar Interbody Fusion: A Prospective Patient Satisfaction Outcome Assessment , 2005, Journal of spinal disorders & techniques.

[17]  J. Burkus.  Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. , 2004, Journal of neurosurgery. Spine.

[18]  C. Branch,et al.  Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. , 2004, The spine journal : official journal of the North American Spine Society.

[19]  T. Lanman,et al.  Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to poly(L-lactide-co-D,L-lactide) bioresorbable implants. , 2004, Neurosurgical focus.

[20]  F. Forriol,et al.  The incorporation of different sorts of cancellous bone graft and the reaction of the host bone. A histomorphometric study in sheep , 2004, International Orthopaedics.

[21]  H. Seeherman,et al.  Locally delivered rhBMP‐2 enhances bone ingrowth and gap healing in a canine model , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  W. Friess,et al.  Collagen sponges for bone regeneration with rhBMP-2. , 2003, Advanced drug delivery reviews.

[23]  E. Schneider,et al.  Resorption patterns of calcium-phosphate cements in bone. , 2003, Journal of biomedical materials research. Part A.

[24]  David S Baskin,et al.  A Prospective, Randomized, Controlled Cervical Fusion Study Using Recombinant Human Bone Morphogenetic Protein-2 With the CORNERSTONE-SR™ Allograft Ring and the ATLANTIS™ Anterior Cervical Plate , 2003, Spine.

[25]  T. Zdeblick,et al.  Is INFUSE Bone Graft Superior to Autograft Bone? An Integrated Analysis of Clinical Trials Using the LT-CAGE Lumbar Tapered Fusion Device , 2003, Journal of spinal disorders & techniques.

[26]  J. Burkus,et al.  Radiographic Assessment of Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein Type 2 , 2003, Spine.

[27]  P. Morberg,et al.  Response of a Calcium Sulfate Bone Graft Substitute in a Confined Cancellous Defect , 2003, Clinical orthopaedics and related research.

[28]  A. Turner,et al.  Evaluation of 70/30 D,L-PLa for use as a resorbable interbody fusion cage. , 2002, Orthopedics.

[29]  C. Dickman,et al.  Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages , 2002, Journal of spinal disorders & techniques.

[30]  J. Lane,et al.  Safety Profile for the Clinical Use of Bone Morphogenetic Proteins in the Spine , 2002, Spine.

[31]  J. Wozney.  Overview of Bone Morphogenetic Proteins , 2002, Spine.

[32]  H. Seeherman,et al.  Bone Morphogenetic Protein Delivery Systems , 2002, Spine.

[33]  H. Sandhu,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 in Spinal Fusion Applications , 2002, Spine.

[34]  S. Boden,et al.  Overview of the Biology of Lumbar Spine Fusion and Principles for Selecting a Bone Graft Substitute , 2002, Spine.

[35]  J. Michael Kabo,et al.  Histologic Evaluation of the Efficacy of rhBMP-2 Compared With Autograft Bone in Sheep Spinal Anterior Interbody Fusion , 2002, Spine.

[36]  J. Wozney,et al.  Clinical evaluation of recombinant human bone morphogenetic protein-2. , 2002, Clinical orthopaedics and related research.

[37]  T. Kleeman,et al.  Laparoscopic Anterior Lumbar Interbody Fusion With rhBMP-2: A Prospective Study of Clinical and Radiographic Outcomes , 2001, Spine.

[38]  M. Kumegawa,et al.  Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. , 2000, Bone.

[39]  S. Boden,et al.  The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.

[40]  R. Warren,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Enhance Tendon Healing in a Bone Tunnel , 1999, The American journal of sports medicine.

[41]  M. Marone,et al.  Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. , 1999, Journal of spinal disorders.

[42]  K. Yamato,et al.  Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. , 1999, Biochemical and biophysical research communications.

[43]  J. Fischgrund,et al.  The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.

[44]  R. Delamarter,et al.  Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.

[45]  J. Michael Kabo,et al.  Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.

[46]  K. Chihara,et al.  Stimulatory effect of bone morphogenetic protein‐2 on osteoclast‐like cell formation and bone‐resorbing activity , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[48]  M. Urist,et al.  Bone cell differentiation and growth factors. , 1983, Science.

[49]  A. Turner,et al.  Polyetheretherketone as a biomaterial for spinal applications. , 2006, Biomaterials.

[50]  J. McClellan,et al.  5:08107. Transient reduced mineral density associated with BMP-enhanced spinal fusion , 2005 .

[51]  N. Haas,et al.  Differences in the Fusion and Resorption Activity of Human Osteoclasts After Stimulation with Different Growth Factors Released From a Polylactide Carrier , 2004, Calcified Tissue International.

[52]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.